Vitiligo Gets Long-Missing Definitions for Severity and Relapse
-
By
-
Kerri Miller
-
April 15, 2026
-
2 min
By
Kerri Miller
April 15, 2026
Once-weekly autoinjector approval was based on Phase 3 data, with safety consistent with intravenous administration.
April 28, 2026
Meta-analysis supports multi-feature dermoscopic evaluation.
April 28, 2026
Higher diagnostic accuracy seen in endocrine system disorders and multisystem conditions.
April 7, 2026